Tien-Li Lee has bought AARD on 4 days since Feb 2025

Dr. Tien-Li Lee, M.D. (age 50) is the founder, Chief Executive Officer, Secretary, and Director of Aardvark Therapeutics, Inc. (NASDAQ: AARD), a biotechnology company, since March 2017.( He holds approximately 7.12% ownership in the company, valued at around $16.94M to $45M, and recently purchased 7,000 shares for $101,395 on December 11, 2025, increasing his direct ownership to 1,551,613 shares (with additional indirect holdings).(

Dr. Lee brings over 20 years of experience in biotechnology innovation and executive leadership, with prior roles including Chief Strategy Officer at NantKwest, Inc. (2014-2017), Director of Business Development at Simcere Pharmaceutical Group Ltd. (2011-2013), and various director positions at Scilex Pharmaceuticals, Inc. and related entities (2018-2023).( His expertise spans therapeutics for immunology, cardiovascular, oncology, neurology, and infectious diseases, and he is an inventor or co-inventor of multiple innovations licensed to companies including NantKwest, Simcere, Cellics Therapeutics, and Aardvark.( Dr. Lee holds an undergraduate degree from the University of California, Berkeley, and a doctorate from the University of California San Diego.(

Written by Perplexity from public sources.